Candel Therapeutics, Inc.CADLNASDAQ
LOADING
|||
Net Income Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-134.97%
↓ 115% below average
Average (22q)
-62.67%
Historical baseline
Range
High:152.43%
Low:-374.71%
Volatility
-841.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -134.97% |
| Q2 2025 | -165.00% |
| Q1 2025 | 152.43% |
| Q4 2024 | -32.19% |
| Q3 2024 | 52.12% |
| Q2 2024 | -170.49% |
| Q1 2024 | 25.90% |
| Q4 2023 | -31.54% |
| Q3 2023 | 12.26% |
| Q2 2023 | -9.31% |
| Q1 2023 | -73.03% |
| Q4 2022 | 41.49% |
| Q3 2022 | -109.40% |
| Q2 2022 | -374.71% |
| Q1 2022 | -154.76% |
| Q4 2021 | 109.88% |
| Q3 2021 | 5.37% |
| Q2 2021 | -281.42% |
| Q1 2021 | 57.26% |
| Q4 2020 | -310.26% |
| Q3 2020 | 11.20% |
| Q2 2020 | -62.30% |
| Q1 2020 | 0.00% |